| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |